Are Involved in the Dissolution of Sister Chromatids
Molecular Cell Biology Laboratory, Graduate School of Pharmaceutical Sciences, Tohoku University, Aoba 6-3, Aramaki, Aoba-ku, Sendai 980-8578, Japan,1 Ludwig-Maximilians-Universitat, Lehrstuhl fur Tieranatomie II, Veterinarstrasse 13, D-80539 Munchen, Germany,2 Biosystems Science, School of Advanced Sciences, The Graduate University for Advanced Studies, Shonan Village, Hayama, Kanagawa 240-0193, Japan,3 Department of Medical Genetics and Radiation Biology, Graduate School of Medicine, Osaka University, Suita, Osaka 565-0871, Japan,4 Shujitsu University, School of Pharmacy, Nishigawara, Okayama 703-8516, Japan,5 Tohoku University 21st Century COE Program "Comprehensive Research and Education Center for Planning of Drug Development and Clinical Evaluation," Sendai, Miyagi 980-8578, Japan6
Received 24 April 2006/ Returned for modification 26 May 2006/ Accepted 2 June 2006
Bloom's syndrome (BS) is an autosomal disorder characterized by predisposition to a wide variety of cancers. The gene product whose mutation leads to BS is the RecQ family helicase BLM, which forms a complex with DNA topoisomerase III
(Top3
). However, the physiological relevance of the interaction between BLM and Top3
within the cell remains unclear. We show here that Top3
depletion causes accumulation of cells in G2 phase, enlargement of nuclei, and chromosome gaps and breaks that occur at the same position in sister chromatids. The transition from metaphase to anaphase is also inhibited. All of these phenomena except cell lethality are suppressed by BLM gene disruption. Taken together with the biochemical properties of BLM and Top3
, these data indicate that BLM and Top3
execute the dissolution of sister chromatids.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|